Draft for consultation. UPDATE 1 February 2022: The consultation period is now closed. Thank you to all who have responded. Comments received are currently being reviewed and addressed.
18 November 2021 | Technical document
This publication provides guidance on the choice of antibiotic, dose, route of administration and duration of treatment for common infectious syndromes in alignment with the recommendations for antibiotics included on the WHO Model List of Essential Medicines and Essential Medicines for Children and the WHO AWaRe (Access-Watch-Reserve) classification of antibiotics.
Access to Medicines and Health Products (MHP), Essential Medicines (EML), Health Product Policy and Standards (HPS), Regulation and Prequalification (RPQ)
